Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice

J Clin Invest. 2016 Jan;126(1):404. doi: 10.1172/JCI85325. Epub 2016 Jan 4.
No abstract available

Publication types

  • Published Erratum